Lopez Cecilia M, Yu Peter Y, Zhang Xiaoli, Yilmaz Ayse Selen, London Cheryl A, Fenger Joelle M
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Medical Student Research Program, The Ohio State University College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
PLoS One. 2018 Jan 2;13(1):e0190086. doi: 10.1371/journal.pone.0190086. eCollection 2018.
Osteosarcoma (OSA) is the most common bone tumor in children and dogs; however, no substantial improvement in clinical outcome has occurred in either species over the past 30 years. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and play a fundamental role in cancer. The purpose of this study was to investigate the potential contribution of miR-34a loss to the biology of canine OSA, a well-established spontaneous model of the human disease.
RT-qPCR demonstrated that miR-34a expression levels were significantly reduced in primary canine OSA tumors and canine OSA cell lines as compared to normal canine osteoblasts. In canine OSA cell lines stably transduced with empty vector or pre-miR-34a lentiviral constructs, overexpression of miR-34a inhibited cellular invasion and migration but had no effect on cell proliferation or cell cycle distribution. Transcriptional profiling of canine OSA8 cells possessing enforced miR-34a expression demonstrated dysregulation of numerous genes, including significant down-regulation of multiple putative targets of miR-34a. Moreover, gene ontology analysis of down-regulated miR-34a target genes showed enrichment of several biological processes related to cell invasion and motility. Lastly, we validated changes in miR-34a putative target gene expression, including decreased expression of KLF4, SEM3A, and VEGFA transcripts in canine OSA cells overexpressing miR-34a and identified KLF4 and VEGFA as direct target genes of miR-34a. Concordant with these data, primary canine OSA tumor tissues demonstrated increased expression levels of putative miR-34a target genes.
These data demonstrate that miR-34a contributes to invasion and migration in canine OSA cells and suggest that loss of miR-34a may promote a pattern of gene expression contributing to the metastatic phenotype in canine OSA.
骨肉瘤(OSA)是儿童和犬类中最常见的骨肿瘤;然而,在过去30年中,这两个物种的临床结局均未出现实质性改善。微小RNA(miRNA)是一类小的非编码RNA,可调节基因表达并在癌症中发挥重要作用。本研究的目的是探讨miR-34a缺失对犬骨肉瘤生物学特性的潜在影响,犬骨肉瘤是一种成熟的人类疾病自发模型。
逆转录定量聚合酶链反应(RT-qPCR)表明,与正常犬成骨细胞相比,原发性犬骨肉瘤肿瘤和犬骨肉瘤细胞系中miR-34a的表达水平显著降低。在稳定转导空载体或pre-miR-34a慢病毒构建体的犬骨肉瘤细胞系中,miR-34a的过表达抑制了细胞侵袭和迁移,但对细胞增殖或细胞周期分布没有影响。对具有增强miR-34a表达的犬OSA8细胞进行转录谱分析,结果显示众多基因失调,包括多个miR-34a假定靶标的显著下调。此外,对下调的miR-34a靶基因进行基因本体分析,结果显示与细胞侵袭和运动相关的多个生物学过程富集。最后,我们验证了miR-34a假定靶基因表达的变化,包括在过表达miR-34a的犬骨肉瘤细胞中KLF4、SEM3A和VEGFA转录本的表达降低,并确定KLF4和VEGFA为miR-34a的直接靶基因。与这些数据一致,原发性犬骨肉瘤肿瘤组织中假定的miR-34a靶基因表达水平升高。
这些数据表明miR-34a在犬骨肉瘤细胞的侵袭和迁移中起作用,并提示miR-34a的缺失可能促进一种有助于犬骨肉瘤转移表型的基因表达模式。